About: A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2000 (uk) article scientifique publié en septembre 2000 (fr) im September 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2000 (ast) scientific article published on 01 September 2000 (en)
publication date	wds:Q73043625-95728F1F-3093-4D4C-BA2A-64B3C511CFE9
publication date	2000-09-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q73043625-5C6C426C-B283-4361-A3E6-3BAF1C65AC5A
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702531
cites work	wds:Q73043625-154E9D55-769F-43CE-8730-B2DEF40A6C8E wds:Q73043625-1DD5083D-7051-458A-B9CD-7592B7723EF9 wds:Q73043625-25B01EC8-6524-4813-960D-A1C8F802577B wds:Q73043625-262068D1-5B5A-4BC1-823A-C240AC00DC9E wds:Q73043625-2D652BE0-B661-4B7D-9294-5491D7DD69B8 wds:Q73043625-2EF8E3E4-D47E-413B-9DBB-92AB16E5E3A6 wds:Q73043625-3611681B-CC93-4E43-8F2A-F4EAB21604E7 wds:Q73043625-4632CFC2-771F-4A55-B24D-260630C9067D wds:Q73043625-46642082-26B1-4541-A794-3DD1974086A6 wds:Q73043625-4713DA87-5D2E-4966-9297-2C8A016777F2 wds:Q73043625-4AAEBFD9-768D-410F-96C9-C2E63C402DE7 wds:Q73043625-4F1A8E03-437B-4112-8194-C73272B1AEEC wds:Q73043625-5522BADA-EB4E-4743-9B9F-797858431E5E wds:Q73043625-57532C28-5CB5-4325-B00B-F69494FAEA43 wds:Q73043625-6D9656D6-A268-42A1-B1A6-7EF18E502A3F wds:Q73043625-7C2E5647-CBC4-4D43-8AA5-8F844EB76199 wds:Q73043625-954E0FD5-DC5F-47EC-B1D5-0F9EEE7B94C1 wds:Q73043625-968889B1-CD62-4A6D-980B-08431EDACA9D wds:Q73043625-97B24BDA-1BA0-4F77-84F9-FAD6757B7F21 wds:Q73043625-A21F1553-7678-4237-8F52-EDE6229BD1A2 wds:Q73043625-AA4D0B0D-935D-4212-B006-0F2B081560DB wds:Q73043625-B12F73E3-9EDC-4260-9F9F-9CC36D21742E wds:Q73043625-C562AC6B-2067-4EB6-9182-EF6BA913AC2A wds:Q73043625-DBAA8177-B479-4F2E-B5F7-03E835EEC87E wds:Q73043625-E0B2A26A-D48D-4D83-B7B7-5B6807F5751F wds:Q73043625-E23BBB29-A86E-4CD2-BB37-F16E0B9C795C wds:Q73043625-F51AD800-5FB5-4B15-A31A-28A7BD96C90D wds:Q73043625-FF5676B0-6E4E-43F3-9A79-CD4F2E6FE922
cites work	High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation Factors that influence collection and engraftment of autologous peripheral-blood stem cells The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells Defining a Therapeutic Dose of Peripheral Blood Stem Cells Optimization of peripheral blood stem cell mobilization Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor North American Multicenter Study on flow cytometric enumeration of CD34+ hematopoietic stem cells Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer. Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor. Stem cell factor is a potent synergistic factor in hematopoiesis Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells
author name string	wds:Q73043625-037DDD4D-2732-45A8-863A-9133D1D2D420 wds:Q73043625-12FE40FA-1826-47E6-A1A4-116F19D3CFF7 wds:Q73043625-2410AE0D-34E2-45B3-83A3-53250FF65303 wds:Q73043625-321A66D2-18B9-4B9C-8D91-E064E377A852 wds:Q73043625-354EB100-0106-4334-8930-06B870A02ABB wds:Q73043625-546D0A3D-96D4-4E49-930E-6C21EABF5766 wds:Q73043625-7508035B-11C2-4ED5-A9A8-09F3433A1AF6 wds:Q73043625-7C148B75-BFAC-4EC4-A3E8-7DCFA07D7A2B wds:Q73043625-9A15DC29-829A-450E-8863-B5DFEC7846B9 wds:Q73043625-BF84E471-F740-42E6-B08A-C25254B663A5 wds:Q73043625-C0C2B313-26F1-4F1B-BE55-1AD5204D22D2 wds:Q73043625-C27C910A-4F3A-4DBD-A1B7-65B87EADD123 wds:Q73043625-CC80F9C0-28FF-4B69-BC89-7FEC79F8268B wds:Q73043625-F133F2FA-74CC-4078-84C9-5E4B001AA440
author name string	Perry J Brown RA Wheeler C Gingrich R Stiff P Mason JR Schenkein DP LeMaistre CF Emmanouilides C Luger S Bensinger W Freter C Parker WRL Wyres MR
rdfs:label	A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma (en) A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma (nl)
skos:prefLabel	A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma (en) A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma (nl)
name	A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software